{"id":815551,"date":"2025-02-20T08:10:52","date_gmt":"2025-02-20T13:10:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/"},"modified":"2025-02-20T08:10:52","modified_gmt":"2025-02-20T13:10:52","slug":"mainz-biomed-expands-into-switzerland-with-labor-team-w","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/","title":{"rendered":"Mainz Biomed Expands into Switzerland with labor team w"},"content":{"rendered":"<h2>\nPartnership to Launch DNA-Based Colorectal Cancer Screening Test<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">BERKELEY, Calif. and MAINZ, Germany, Feb.  20, 2025  (GLOBE NEWSWIRE) &#8212; Mainz Biomed N.V. (NASDAQ:MYNZ) (\u201cMainz Biomed\u201d or the \u201cCompany\u201d), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a strategic partnership with labor team w ag (\u201clabor team\u201d), a renowned diagnostic laboratory based in Goldach, Switzerland. This collaboration introduces ColoAlert<sup>\u00ae<\/sup>, a DNA-based colorectal cancer (CRC) screening test to the Swiss market for the very first time, marking Mainz Biomed\u2019s initial footprint in Switzerland.<\/p>\n<p>CRC remains one of the most common yet preventable forms of cancer worldwide. In Switzerland, thousands of new cases are diagnosed annually, underscoring the urgent need for early detection and prevention. The introduction of a DNA-based CRC screening test offers a transformative opportunity to increase participation rates and ensure early detection, aligning with national efforts to reduce CRC-related mortality and improve population health outcomes.<\/p>\n<p>The new partnership combines Mainz Biomed\u2019s expertise in DNA-based diagnostics with labor team w\u2019s strong track record in delivering high-quality laboratory services. Together, the companies will provide a state-of-the-art CRC screening test to individuals across Switzerland.<\/p>\n<p>\u201cWe are thrilled to partner with labor team to bring this innovative CRC screening solution to the Swiss market,\u201d said Guido Baechler, CEO of Mainz Biomed. \u201cBy integrating our cutting-edge technology into labor team\u2019s trusted diagnostic services, we aim to empower individuals with accessible and reliable cancer screening options, ultimately advancing public health.\u201d<\/p>\n<p>Alain Cahen, CEO of labor team, adds \u201cthe introduction of ColoAlert<sup>\u00ae<\/sup> on the Swiss market continues to position labor team as the top innovator of private laboratories, helping more patients access reliable diagnostic tools in key disease areas such as colon cancer screening.<\/p>\n<p>This partnership also marks an important milestone for Mainz Biomed, further expanding its presence in the European market with its flagship product ColoAlert<sup>\u00ae<\/sup>, the first DNA-based CRC screening test in Europe. It aligns with the growing demand for personalized healthcare solutions that prioritize early intervention and prevention.<\/p>\n<p>The DNA-based CRC screening test will be available through labor team w\u00b4s extensive network of healthcare providers starting in the spring 2025.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wn7GSWM0hkOhfTXL8mDTObq-00soTx6ItWNb2i0BDPPBBaFVYqklHBjOzIexClbArAMKLpw1F-l0Y-fhf5Zo2NjQJmyr0mo35U83kGlMAf0jO_gNTg2dV4U72VDTFVWT0YGv2HoT9G4es2VlqK9ZhM7-gkUyvtzJbJeeu_GNr28gGZDBBHc6ZvZXHTMWYqkadExhXAt7L06FSZDXbQeS_3doxEtsAfKuUEfXfjZSIm8=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>Please visit Mainz Biomed\u2019s official website for investors at mainzbiomed.com\/investors\/ for more information <\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>Please follow us to stay up to date:<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fxlgZ7sWpcgLJQGyPpEjrRA4kIz8pEYosIVRclsyGzYIsISpqms19itgL21Me-10BCikZ71CcrhhxzFFWAY5bA4nWJJzP-Pofqk48az20Ys25RzvN8j89QlDSHBfOhwA\" rel=\"nofollow\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hdmGkfPg9EIVcg5fYBVU8dJvURk5ICWJjFSHPc9WEP6xMI0u2dSlUTDbnWkJO2FyNNf-MBPhO10eT7eyazFNSnVoa5tVKvaxTg4gfg7HRWo=\" rel=\"nofollow\" target=\"_blank\"><strong>X (Previously Twitter)<\/strong><\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_5RNIHm22zKB2CDxW5ix6JALMb0s5b3RkKevUZRBPvonk2Q3vD16t4VgI1zKLJ4yeQb5bcD6R0LiuiWHr_RxUcBu9u3cYZ2vXPKxEU-uSgA=\" rel=\"nofollow\" target=\"_blank\"><strong>Facebook<\/strong><\/a><\/p>\n<p>\n        <strong>About Mainz Biomed NV<\/strong><br \/>\n        <br \/>Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company\u2019s flagship product is ColoAlert<sup>\u00ae<\/sup>, an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer. ColoAlert<sup>\u00ae<\/sup> is marketed across Europe and the United Arab Emirates. The Company is currently running a pivotal FDA clinical study for US regulatory approval. Mainz Biomed\u2019s product candidate portfolio also includes PancAlert, an early-stage pancreatic cancer screening test based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ac_ddCAO4tNaR-lfTRP3OPjF7LykAwUa_6ycgr3G6JDLapWp3qQWvJ4yT6bLcq22OWxhyByzJgWv1SqB9QrsWqszhHs43vuT41j4Qnuo2dw=\" rel=\"nofollow\" target=\"_blank\"><strong>mainzbiomed.com<\/strong><\/a><strong> or follow us on <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fxlgZ7sWpcgLJQGyPpEjrUT2ye8l2XAl9q7CENQ--zrtXj75Iz0p2ZEXEPNc-1_1WuYlp2XdmwqrXEJxhDgs1y06lsGPwHFUMOFxiW3aEwswypxpaVxEFjsUAB-apT0J\" rel=\"nofollow\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a><strong>, <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mpbjyEC2fRIg7HgtSqFPb2sz-bbmOt7nH9htVnkGKlFsst4QU1IDsIOiHzJI-rPwI7zfpiS2B_IjqfJzqvb_W4mLk7W60abD_i6jmOk4B80=\" rel=\"nofollow\" target=\"_blank\"><strong>Twitter<\/strong><\/a><strong> and <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_5RNIHm22zKB2CDxW5ix6KXvjFADjJlrxIVuAKx3GJD0I9oW48A5mL5ts1og8VrWRQoOtvrk7w1m0Oi4aP01cu_Opt0jZpxuZ5DtW3ipeE4=\" rel=\"nofollow\" target=\"_blank\"><strong>Facebook<\/strong><\/a><strong>.<\/strong><\/p>\n<p>\n        <strong>About labor team <\/strong><br \/>\n        <br \/>labor team w ag, based in Goldach in the canton of St Gallen, is one of Switzerland&#8217;s leading private medical laboratories. Established in 2001 and run by medical professionals, it is now the fourth largest laboratory in Switzerland, with over 300 employees. labor team is one of the few laboratories that serves the whole of Switzerland. It provides professional services for disease prevention, diagnosis, monitoring and treatment of illnesses. The company covers every aspect of laboratory medicine and pathology. It performs medical tests and analyses in a state-of-the-art central laboratory, resulting in top quality services, a high level of flexibility and fast turnarounds. <br \/>For more information, visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=huNSndzwz8Ta8SiDoqtRVcbjfOGvFeC8jaVKbDl4REwlyHdK8-ochjNPRwoispK4kIFWYHYfiqSXt0X6CX9VmCIiXaVJP_m-nMe-PPrDZnw=\" rel=\"nofollow\" target=\"_blank\">www.laborteam.ch<\/a><\/p>\n<p>\n        <strong>For media inquiries<\/strong><br \/>\n        <br \/>MC Services AG<br \/>Anne Hennecke\/Simone Neeten<br \/>+49 211 529252 22<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ac_ddCAO4tNaR-lfTRP3OAg00iTjkvlE8emJbyUWSoJ-2vKMImnBTddk95jq1nA-J5uV1DsqR10mMEsATXim9W7yBqR-ZMQRHb8RNAItHBsyI9c7Z7j24KuIAalTjbKb\" rel=\"nofollow\" target=\"_blank\"><strong>mainzbiomed@mc-services.eu<\/strong><\/a><br \/><strong>For investor inquiries, please contact <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yu4efdg6BjMIq_EmJg68BZXES9QFDY6Lz-5glo7idvQcm4Z9VV9A-NG8moCsozN3je-qY_DRyFKZNNGbXN9YZ9PhQeXEqNyP_-PaJX9k8gE=\" rel=\"nofollow\" target=\"_blank\"><strong>ir@mainzbiomed.com<\/strong><\/a><\/p>\n<p><strong>Forward-Looking Statements<\/strong><br \/>Certain statements made in this press release are \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as \u201canticipate\u201d, \u201cbelieve\u201d, \u201cexpect\u201d, \u201cestimate\u201d, \u201cplan\u201d, \u201coutlook\u201d, and \u201cproject\u201d and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, actual results may differ materially from the Company\u2019s expectations or projections. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the failure to meet projected development and related targets; (ii) changes in applicable laws or regulations; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the \u201cSEC\u201d) by the Company. Additional information concerning these and other factors that may impact the Company\u2019s expectations and projections can be found in its initial filings with the SEC, including its annual report on Form 20-F filed on April 9, 2024. The Company\u2019s SEC filings are available publicly on the SEC\u2019s website at www.sec.gov. Any forward-looking statement made by us in this press release is based only on information currently available to Mainz Biomed and speaks only as of the date on which it is made. Mainz Biomed undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NzM0ZWFhZTgtOTg1Ny00NmQ5LTg2OTgtYTNjM2Y5NGI3MTE3LTEyMzU2NDI=\/tiny\/Mainz-BioMed-NV.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Partnership to Launch DNA-Based Colorectal Cancer Screening Test BERKELEY, Calif. and MAINZ, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Mainz Biomed N.V. (NASDAQ:MYNZ) (\u201cMainz Biomed\u201d or the \u201cCompany\u201d), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a strategic partnership with labor team w ag (\u201clabor team\u201d), a renowned diagnostic laboratory based in Goldach, Switzerland. This collaboration introduces ColoAlert\u00ae, a DNA-based colorectal cancer (CRC) screening test to the Swiss market for the very first time, marking Mainz Biomed\u2019s initial footprint in Switzerland. CRC remains one of the most common yet preventable forms of cancer worldwide. In Switzerland, thousands of new cases are diagnosed annually, underscoring the urgent need for early detection and prevention. The introduction &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Mainz Biomed Expands into Switzerland with labor team w&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815551","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mainz Biomed Expands into Switzerland with labor team w - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mainz Biomed Expands into Switzerland with labor team w - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Partnership to Launch DNA-Based Colorectal Cancer Screening Test BERKELEY, Calif. and MAINZ, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Mainz Biomed N.V. (NASDAQ:MYNZ) (\u201cMainz Biomed\u201d or the \u201cCompany\u201d), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a strategic partnership with labor team w ag (\u201clabor team\u201d), a renowned diagnostic laboratory based in Goldach, Switzerland. This collaboration introduces ColoAlert\u00ae, a DNA-based colorectal cancer (CRC) screening test to the Swiss market for the very first time, marking Mainz Biomed\u2019s initial footprint in Switzerland. CRC remains one of the most common yet preventable forms of cancer worldwide. In Switzerland, thousands of new cases are diagnosed annually, underscoring the urgent need for early detection and prevention. The introduction &hellip; Continue reading &quot;Mainz Biomed Expands into Switzerland with labor team w&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T13:10:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mainz Biomed Expands into Switzerland with labor team w\",\"datePublished\":\"2025-02-20T13:10:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/\"},\"wordCount\":956,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/\",\"name\":\"Mainz Biomed Expands into Switzerland with labor team w - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==\",\"datePublished\":\"2025-02-20T13:10:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mainz-biomed-expands-into-switzerland-with-labor-team-w\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mainz Biomed Expands into Switzerland with labor team w\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mainz Biomed Expands into Switzerland with labor team w - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/","og_locale":"en_US","og_type":"article","og_title":"Mainz Biomed Expands into Switzerland with labor team w - Market Newsdesk","og_description":"Partnership to Launch DNA-Based Colorectal Cancer Screening Test BERKELEY, Calif. and MAINZ, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Mainz Biomed N.V. (NASDAQ:MYNZ) (\u201cMainz Biomed\u201d or the \u201cCompany\u201d), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a strategic partnership with labor team w ag (\u201clabor team\u201d), a renowned diagnostic laboratory based in Goldach, Switzerland. This collaboration introduces ColoAlert\u00ae, a DNA-based colorectal cancer (CRC) screening test to the Swiss market for the very first time, marking Mainz Biomed\u2019s initial footprint in Switzerland. CRC remains one of the most common yet preventable forms of cancer worldwide. In Switzerland, thousands of new cases are diagnosed annually, underscoring the urgent need for early detection and prevention. The introduction &hellip; Continue reading \"Mainz Biomed Expands into Switzerland with labor team w\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T13:10:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mainz Biomed Expands into Switzerland with labor team w","datePublished":"2025-02-20T13:10:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/"},"wordCount":956,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/","name":"Mainz Biomed Expands into Switzerland with labor team w - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==","datePublished":"2025-02-20T13:10:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NSM0MDIwNjMyMTUjMjIyNDA4OQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mainz-biomed-expands-into-switzerland-with-labor-team-w\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mainz Biomed Expands into Switzerland with labor team w"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815551"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815551\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}